CAPRICORN-19
Recruiting
18-99 years
All
Phase
N/A
280 participants needed
1 Location
Brief description of study
In this study, the Investigators at the University of Pennsylvania will assess organ-specific biomarker profiles (proteins and metabolites), in order to better understand biologic processes, the interplay between the heart and extracardiac organs, and their role in human disease, with an emphasis on cardiovascular disease. The study will specifically focus on the role of the liver, kidneys, lungs, and skeletal muscle, and their interactions with the heart as determinants of cardiovascular disease. This will be achieved by drawing biological specimens from key organs among patients who have received a COVID-19 diagnosis. Study participants will undergo a series of non-invasive procedures during their visit to better understand the role and function of these systems post-COVID infection.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: COVID-19,Blood Pressure,Respiratory,Cardiac function,Renal function,Pulmonary function
-
Age: Between 18 Years - 99 Years
-
Gender: All
Subjects 18+ are currently being enrolled from the Philadelphia, PA area. Documentation regarding COVID-19 infection rate and recent labs indicating creatinine and/or eGFR are required to determine participation eligibility. A pregnancy test may be required for persons of reproductive age.
Updated on
01 Aug 2024.
Study ID: 844349
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
